CDCP1
Basic information
Region (hg38): 3:45082277-45146422
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CDCP1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 42 | 48 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 42 | 4 | 3 |
Variants in CDCP1
This is a list of pathogenic ClinVar variants found in the CDCP1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-45085658-G-C | not specified | Uncertain significance (Dec 14, 2023) | ||
3-45085699-C-T | not specified | Likely benign (Jan 30, 2024) | ||
3-45085802-C-A | not specified | Uncertain significance (Dec 13, 2022) | ||
3-45085805-T-C | not specified | Uncertain significance (Oct 17, 2023) | ||
3-45085861-C-T | Benign (May 21, 2018) | |||
3-45085895-C-T | not specified | Uncertain significance (Dec 13, 2022) | ||
3-45085972-C-T | not specified | Uncertain significance (Dec 19, 2022) | ||
3-45085975-C-T | not specified | Uncertain significance (Jul 25, 2023) | ||
3-45085978-T-C | not specified | Uncertain significance (Mar 15, 2024) | ||
3-45085979-T-A | Myoepithelial tumor | Uncertain significance (Nov 01, 2022) | ||
3-45085989-T-G | not specified | Uncertain significance (Jun 13, 2024) | ||
3-45086035-C-T | not specified | Uncertain significance (Mar 01, 2023) | ||
3-45089123-A-G | not specified | Uncertain significance (Jun 29, 2022) | ||
3-45089127-G-C | not specified | Uncertain significance (Apr 15, 2024) | ||
3-45089130-T-C | not specified | Likely benign (Dec 14, 2023) | ||
3-45091263-T-C | not specified | Uncertain significance (Oct 03, 2022) | ||
3-45091299-C-T | not specified | Uncertain significance (Aug 16, 2021) | ||
3-45091314-T-G | not specified | Uncertain significance (Apr 23, 2024) | ||
3-45091332-G-A | not specified | Uncertain significance (Mar 18, 2024) | ||
3-45091377-C-T | not specified | Uncertain significance (Mar 31, 2023) | ||
3-45091380-C-T | Benign (May 24, 2018) | |||
3-45091385-C-T | not specified | Uncertain significance (Sep 15, 2021) | ||
3-45091414-C-G | not specified | Uncertain significance (Mar 28, 2022) | ||
3-45091419-C-T | not specified | Likely benign (Apr 12, 2022) | ||
3-45093281-G-T | not specified | Uncertain significance (Aug 02, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CDCP1 | protein_coding | protein_coding | ENST00000296129 | 9 | 64145 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000100 | 0.999 | 125717 | 0 | 31 | 125748 | 0.000123 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.37 | 395 | 480 | 0.824 | 0.0000286 | 5482 |
Missense in Polyphen | 97 | 159.95 | 0.60644 | 1918 | ||
Synonymous | 0.842 | 187 | 202 | 0.925 | 0.0000129 | 1710 |
Loss of Function | 3.03 | 12 | 29.8 | 0.402 | 0.00000165 | 324 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000337 | 0.000337 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000326 | 0.000272 |
Finnish | 0.000185 | 0.000185 |
European (Non-Finnish) | 0.0000932 | 0.0000879 |
Middle Eastern | 0.000326 | 0.000272 |
South Asian | 0.000196 | 0.000196 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in cell adhesion and cell matrix association. May play a role in the regulation of anchorage versus migration or proliferation versus differentiation via its phosphorylation. May be a novel marker for leukemia diagnosis and for immature hematopoietic stem cell subsets. Belongs to the tetraspanin web involved in tumor progression and metastasis. {ECO:0000269|PubMed:11466621, ECO:0000269|PubMed:12799299, ECO:0000269|PubMed:15153610, ECO:0000269|PubMed:16007225, ECO:0000269|PubMed:16404722, ECO:0000269|PubMed:8647901}.;
- Pathway
- miR-targeted genes in epithelium - TarBase;miR-targeted genes in leukocytes - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase
(Consensus)
Recessive Scores
- pRec
- 0.362
Intolerance Scores
- loftool
- 0.777
- rvis_EVS
- 0.27
- rvis_percentile_EVS
- 70.73
Haploinsufficiency Scores
- pHI
- 0.113
- hipred
- Y
- hipred_score
- 0.598
- ghis
- 0.471
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.158
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cdcp1
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; neoplasm;
Gene ontology
- Biological process
- Cellular component
- extracellular region;plasma membrane;integral component of membrane
- Molecular function
- protein binding